143 related articles for article (PubMed ID: 24385272)
1. Cost-effectiveness of optimizing acute stroke care services for thrombolysis.
Penaloza-Ramos MC; Sheppard JP; Jowett S; Barton P; Mant J; Quinn T; Mellor RM; Sims D; Sandler D; McManus RJ;
Stroke; 2014 Feb; 45(2):553-62. PubMed ID: 24385272
[TBL] [Abstract][Full Text] [Related]
2. Is the Cost-Effectiveness of Stroke Thrombolysis Affected by Proportion of Stroke Mimics?
Liberman AL; Choi HJ; French DD; Prabhakaran S
Stroke; 2019 Feb; 50(2):463-468. PubMed ID: 30572813
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
[TBL] [Abstract][Full Text] [Related]
4. A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke.
Boudreau DM; Guzauskas G; Villa KF; Fagan SC; Veenstra DL
Ann Emerg Med; 2013 Jan; 61(1):46-55. PubMed ID: 22633340
[TBL] [Abstract][Full Text] [Related]
5. Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III.
Simpson KN; Simpson AN; Mauldin PD; Palesch YY; Yeatts SD; Kleindorfer D; Tomsick TA; Foster LD; Demchuk AM; Khatri P; Hill MD; Jauch EC; Jovin TG; Yan B; von Kummer R; Molina CA; Goyal M; Schonewille WJ; Mazighi M; Engelter ST; Anderson C; Spilker J; Carrozzella J; Ryckborst KJ; Janis LS; Broderick JP;
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28483774
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
[TBL] [Abstract][Full Text] [Related]
7. Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?
Pandya A; Soeteman DI; Gupta A; Kamel H; Mushlin AI; Rosenthal MB
Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006492. PubMed ID: 32615799
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.
Pan Y; Chen Q; Zhao X; Liao X; Wang C; Du W; Liu G; Liu L; Wang C; Wang Y; Wang Y;
PLoS One; 2014; 9(10):e110525. PubMed ID: 25329637
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
Ehlers L; Andersen G; Clausen LB; Bech M; Kjølby M
Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
[TBL] [Abstract][Full Text] [Related]
11. Potential gains and costs from increasing access to thrombolysis for acute ischemic stroke patients in New Zealand hospitals.
Te Ao B; Brown P; Fink J; Vivian M; Feigin V
Int J Stroke; 2015 Aug; 10(6):903-10. PubMed ID: 24206567
[TBL] [Abstract][Full Text] [Related]
12. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Cost-Effectiveness of Mechanical Thrombectomy Beyond 6 Hours Following Advanced Imaging in the United Kingdom.
Peultier AC; Redekop WK; Allen M; Peters J; Eker OF; Severens JL
Stroke; 2019 Nov; 50(11):3220-3227. PubMed ID: 31637975
[TBL] [Abstract][Full Text] [Related]
14. National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.
Ehlers L; Müskens WM; Jensen LG; Kjølby M; Andersen G
CNS Drugs; 2008; 22(1):73-81. PubMed ID: 18072816
[TBL] [Abstract][Full Text] [Related]
15. Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom.
Earnshaw SR; McDade C; Chapman AM; Jackson D; Schwamm L
Clin Ther; 2012 Jul; 34(7):1544-58. PubMed ID: 22695225
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis.
Earnshaw SR; Jackson D; Farkouh R; Schwamm L
Stroke; 2009 May; 40(5):1710-20. PubMed ID: 19286581
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China.
Pan Y; Zhang L; Li Z; Meng X; Wang Y; Li H; Liu L; Wang Y
Stroke; 2020 Apr; 51(4):1265-1271. PubMed ID: 32019480
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Magnetic Resonance Imaging-Guided Thrombolysis for Patients With Stroke With Unknown Time of Onset.
Muntendorf LK; Konnopka A; König HH; Boutitie F; Ebinger M; Endres M; Fiebach JB; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G
Value Health; 2021 Nov; 24(11):1620-1627. PubMed ID: 34711362
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of CT perfusion for selecting patients for intravenous thrombolysis: a US hospital perspective.
Jackson D; Earnshaw SR; Farkouh R; Schwamm L
AJNR Am J Neuroradiol; 2010 Oct; 31(9):1669-74. PubMed ID: 20538823
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
